[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-343286-105":59,"doc-detail-343286-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","stabilization-of-tgf-receptor-1-by-a-receptor-associated-adaptor-dictates-feedback-activation-of-the-tgf-signaling-pathway-to-maintain-liver-cancer-stemness-and-drug-resistance","Stabilization of TGF-β Receptor 1 by a Receptor-Associated Adaptor Dictates Feedback Activation of the TGF-β Signaling Pathway to Maintain Liver Cancer Stemness and Drug Resistance","","Disruption of the transforming growth factor-β (TGF-β) signaling pathway reshapes cancer stem cells and influences drug sensitivity, yet feedback control mechanisms that drive drug-resistant stem-like cells remain insufficiently defined. A genome-wide CRISPR activation screen identifies TGFBRAP1 as a TGF-β-inducible positive feedback regulator that stabilizes TGFBR1, promotes liver cancer stemness, and modulates responses to tyrosine kinase inhibitors. TGFBRAP1 competes with Smurf1/2 to impair receptor degradation, and hyperactive signaling induces TGFBRAP1, amplifying TGF-β activity. In hepatocellular carcinoma cohorts, TGFBRAP1 expression links to TGFBR1 levels, survival, and recurrence; selective TGFBRAP1 stabilization blockade reduces Regorafenib resistance by lowering cancer stemness. ",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/stabilization-of-tgf-receptor-1-by-a-receptor-associated-adaptor-dictates-feedback-activation-of-the-tgf-signaling-pathway-to-maintain-liver-cancer-stemness-and-drug-resistance/343286/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/stabilization-of-tgf-receptor-1-by-a-receptor-associated-adaptor-dictates-feedback-activation-of-the-tgf-signaling-pathway-to-maintain-liver-cancer-stemness-and-drug-resistance/343286.png","ImageObject",300,407,{"name":92,"@type":93},"Riley","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What role does TGFBRAP1 play in TGF-β signaling and drug resistance?","Question",{"text":112,"@type":113},"TGFBRAP1 acts as a TGF-β-inducible positive feedback regulator by stabilizing TGFBR1 and potentiating TGF-β signaling. Its activity is linked to liver cancer stemness and resistance to drugs such as tyrosine kinase inhibitors and Regorafenib.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does TGFBRAP1 stabilize TGFBR1 mechanistically?",{"text":117,"@type":113},"TGFBRAP1 competes with the E3 ubiquitin ligases Smurf1/2 for binding to TGFBR1. This impairs receptor poly-ubiquitination and proteasomal degradation, thereby sustaining signaling.",{"name":119,"@type":110,"acceptedAnswer":120},"How is the feedback activation reinforced in drug-resistant CSC-like cells?",{"text":121,"@type":113},"Hyperactive TGF-β signaling up-regulates TGFBRAP1 expression in drug-resistant CSC-like cells. This creates an amplification loop that further enhances TGF-β pathway activity and supports stemness.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},343286,1790118652,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1374391975076,"https://ap-avatar.wpscdn.com/avatar/14000253ca4ec9f6853?x-image-process=image/resize,m_fixed,w_180,h_180&k=1783305029341752051","RESEARCH ARTICLE  \n[www.advancedscience.com](www.advancedscience.com)  \nStabilization ofTGF-􀀂 Receptor 1 by a Receptor-Associated Adaptor Dictates Feedback Activation ofthe TGF-􀀂 Signaling Pathway to Maintain Liver Cancer Stemness and Drug Resistance  \nKewei Liu, Fanxuan Tian, Xu Chen, Biyin Liu, Shuoran Tian, Yongying Hou, Lei Wang, Mengyi Han, Shiying Peng, Yuting Tan, Yuwei Pan, Zhaole Chu, Jinyang Li, Linrong Che, Dongfeng Chen, Liangzhi Wen, Zhongyi Qin, Xianfeng Li, Junyu Xiang, Xiu-wu Bian, Qin Liu,* Xiaoli Ye,* Tao Wang,* and Bin Wang*  \nDysregulation of the transforming growth factor-􀀂 (TGF-􀀂) signaling pathway regulates cancer stem cells (CSCs) and drug sensitivity, whereas it remains largely unknown how feedback regulatory mechanisms are hijacked to fuel drug-resistant CSCs. Through a genome-wide CRISPR activation screen utilizing stem-like drug-resistant properties as a readout, the TGF-􀀂 receptor-associated binding protein 1 (TGFBRAP1) is identiﬁed as a  \nTGF-􀀂-inducible positive feedback regulator that governs sensitivity to tyrosine kinase inhibitors (TKIs) and promotes liver cancer stemness. By interacting with and stabilizing the TGF-􀀂 receptor type 1 (TGFBR1), TGFBRAP1 plays an important role in potentiating TGF-􀀂 signaling. Mechanistically, TGFBRAP1 competes with E3 ubiquitin ligases Smurf1/2 for binding to TGFΒR1, leading to impaired receptor poly-ubiquitination and proteasomal degradation. Moreover, hyperactive TGF-􀀂 signaling in turn up-regulates TGFBRAP1 expression in drug-resistant CSC-like cells, thereby constituting a previously uncharacterized feedback mechanism to amplify TGF-􀀂 signaling. As such, TGFBRAP1 expression is correlated with TGFΒR1 levels and TGF-􀀂 signaling activity in hepatocellular carcinoma (HCC) tissues, as well as overall survival and disease recurrence in multiple HCC cohorts. Therapeutically, blocking TGFBRAP1-mediated stabilization ofTGFBR1 by selective inhibitors alleviates Regorafenib resistance via reducing CSCs. Collectively, targeting feedback machinery ofTGF-􀀂 signaling pathway may bean actionable approach to mitigate drug resistance and liver cancer stemness.  \n1. Introduction  \nThe transforming growth factor-􀀂 (TGF-􀀂) signaling pathway is essential for embryonic development, tissue homeostasis, and regeneration through coordinating cell fate commitment and functional plasticity.[1] Aberrancies of TGF-􀀂 signaling, particularly in various epithelial tissues, contribute to human tumorigenesis and therapeutic resistance by acting on a subpopulation of cancer stem cells (CSCs) . [2–4 Active TGF-􀀂1 binds to TGF-􀀂 receptor type 2  \n(R2, TGFBR2), which forms a heteromeric complex with TGF-􀀂 receptor type I (R1, TGFBR1) to mediates its phosphorylation. The ligand-activated receptor complex phosphorylates and activates SMAD2 and SMAD3, which together form a complex that subsequently translocate into the nucleus and acts as key cofactors in the transcriptional activation of target genes. [1,5] As such, soluble TGF-􀀂1, either produced in an autocrine fashion or released from the tumor microenvironment, plays important roles in dictating the stem-like drugresistant properties in a variety of human cancers. [2,6] For example, TGF-􀀂 induces  \nK. Liu, X. Ye  \nEngineering Research Center of Coptis Development and Utilization (Ministry of Education), School of Life Sciences  \nSouthwest University  \nChongqing 400715, P. R. China  \nE-mail: [yexiaoli@swu.edu.cn](yexiaoli@swu.edu.cn)  \nThe ORCID identiﬁcation number(s) for the author(s) of this article  \ncan be found under [https://doi.org/10.1002/advs.202402327](https://doi.org/10.1002/advs.202402327)[ ](https://doi.org/10.1002/advs.202402327)© 2024 The Author(s). Advanced Science published by Wiley-VCH GmbH. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \nDOI: 10.1002/advs.202402327  \nK. ","cbCaiexNG11zqdIo","https://ap.wps.com/l/cbCaiexNG11zqdIo","pdf",6926606,17,"English","# Introduction\n## TGF-β signaling and cancer stem cell regulation\n## Feedback control and therapeutic resistance\n## Study rationale and approach","[{\"question\":\"What role does TGFBRAP1 play in TGF-β signaling and drug resistance?\",\"answer\":\"TGFBRAP1 acts as a TGF-β-inducible positive feedback regulator by stabilizing TGFBR1 and potentiating TGF-β signaling. Its activity is linked to liver cancer stemness and resistance to drugs such as tyrosine kinase inhibitors and Regorafenib.\"},{\"question\":\"How does TGFBRAP1 stabilize TGFBR1 mechanistically?\",\"answer\":\"TGFBRAP1 competes with the E3 ubiquitin ligases Smurf1/2 for binding to TGFBR1. This impairs receptor poly-ubiquitination and proteasomal degradation, thereby sustaining signaling.\"},{\"question\":\"How is the feedback activation reinforced in drug-resistant CSC-like cells?\",\"answer\":\"Hyperactive TGF-β signaling up-regulates TGFBRAP1 expression in drug-resistant CSC-like cells. This creates an amplification loop that further enhances TGF-β pathway activity and supports stemness.\"}]","Stabilization of TGF-β Receptor 1 by a Receptor-Associated Adaptor Dictates Feedback Activation of the TGF-β Signaling Pathway to Maintain Liver Cancer Stemness and Drug Resistance | PDF",1790050609,43,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1937e8c7fc20988d2580077acc91ca06.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5e354f44a92b8b2ceed3dd0fe5b6063c.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f3e01e799d8f5659c7a75f1d6adbcfdb.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/711a4b1bfa5045607b70c99a5a5d584e.webp",980,1287]